[go: up one dir, main page]

BRPI0408814A - composição farmacêutica, e, alimento para o cuidado da saúde - Google Patents

composição farmacêutica, e, alimento para o cuidado da saúde

Info

Publication number
BRPI0408814A
BRPI0408814A BRPI0408814-0A BRPI0408814A BRPI0408814A BR PI0408814 A BRPI0408814 A BR PI0408814A BR PI0408814 A BRPI0408814 A BR PI0408814A BR PI0408814 A BRPI0408814 A BR PI0408814A
Authority
BR
Brazil
Prior art keywords
inhibiting
health care
food
pharmaceutical composition
activity
Prior art date
Application number
BRPI0408814-0A
Other languages
English (en)
Inventor
Sung-Sick Woo
Tae-Hyung Jo
Dong-Seon Kim
Sun-Young Sung
Seon-Gil Do
Young-Chul Lee
Jeong-Bum Nam
Jong-Ha Ryu
Kang-Woo Lee
Hee-Sun Sung
Young-Moon Heo
Mi-Sun Oh
Ji-Nyeo Cho
Soo-Kyung Sung
Ju-Yeon Lee
Tae-Woo Kim
Ji-Sook Song
Seoung-Ho Lee
Mi Ran Kim
Original Assignee
Unigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020030019229A external-priority patent/KR100417243B1/ko
Priority claimed from KR1020030019230A external-priority patent/KR100417244B1/ko
Application filed by Unigen Inc filed Critical Unigen Inc
Publication of BRPI0408814A publication Critical patent/BRPI0408814A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA, E, ALIMENTO PARA O CUIDADO DA SAúDE". A presente invenção refere-se a uma composição compreendendo um extrato de planta de bambu para a prevenção e o tratamento de doença inflamatória e de circulação sanguínea. Os extratos de planta de bambu possuem atividade antiinflamatória potente pela inibição da produção de NO e atividade de melhoria de circulação sanguínea pela inibição da atividade de elastase e cicatrização de ferimento de célula endotelial vascular, ativação da expressão de u-PA e inibição da expressão de PAI-1, abaixamento do depósito de colesterol e inibição da formação de neoíntima, portanto pode ser usado como um alimento para o cuidado da saúde ou terapêutico para o tratamento e a prevenção de doenças inflamatórias e de circulação sanguínea.
BRPI0408814-0A 2003-03-27 2004-03-27 composição farmacêutica, e, alimento para o cuidado da saúde BRPI0408814A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020030019229A KR100417243B1 (ko) 2003-03-27 2003-03-27 항염증 활성을 지닌 분죽 추출물을 함유하는 염증성 질환의 예방 및 치료용 약학조성물
KR1020030019230A KR100417244B1 (ko) 2003-03-27 2003-03-27 분죽 추출물을 함유하는 혈액순환개선용 약학조성물
PCT/KR2004/000708 WO2004098624A1 (en) 2003-03-27 2004-03-27 Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease

Publications (1)

Publication Number Publication Date
BRPI0408814A true BRPI0408814A (pt) 2006-04-04

Family

ID=36118391

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408814-0A BRPI0408814A (pt) 2003-03-27 2004-03-27 composição farmacêutica, e, alimento para o cuidado da saúde

Country Status (7)

Country Link
US (4) US20060078632A1 (pt)
EP (2) EP1633379A4 (pt)
JP (1) JP4684893B2 (pt)
AU (1) AU2004235702B2 (pt)
BR (1) BRPI0408814A (pt)
CA (1) CA2520207C (pt)
WO (1) WO2004098624A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
CN101837003B (zh) * 2002-04-30 2013-09-04 尤尼根公司 作为治疗剂的包含无取代b环类黄酮和黄烷混合物的组合物
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク． 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
CN1798568B (zh) 2003-04-04 2011-05-11 尤尼根制药公司 用于哺乳动物皮肤护理的双重环氧合酶(cox)以及脂氧合酶(lox)抑制剂的组合物
CN1528197A (zh) * 2003-10-08 2004-09-15 ƽ 竹叶抗氧化物及其用途
KR100720971B1 (ko) * 2004-06-11 2007-05-22 주식회사 유니젠 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물
JP5097983B2 (ja) * 2005-02-22 2012-12-12 学校法人東京農業大学 抗酸化活性を有する組成物の製造方法
KR100720973B1 (ko) * 2005-03-18 2007-05-22 주식회사 유니젠 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물
GB0610790D0 (en) * 2006-06-02 2006-07-12 Provexis Natural Products Ltd Therapeutic uses of tomato extracts
JP2008081440A (ja) * 2006-09-27 2008-04-10 Noevir Co Ltd アロマターゼ活性促進剤
KR100761248B1 (ko) * 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
WO2008123102A1 (ja) * 2007-03-19 2008-10-16 Yuuzou Tsuchida 抗ウイルス剤
JP5164454B2 (ja) * 2007-07-03 2013-03-21 英元 日下 孟宗竹の熱水抽出物を有効成分とする血行促進剤、関節痛緩和剤、腱鞘炎緩和剤、及び肩凝り緩和剤
US20090149792A1 (en) * 2007-12-06 2009-06-11 Kreetech International Corp. Composition for wound management
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
KR101727731B1 (ko) * 2009-07-10 2017-04-17 주식회사 케미메디 담죽엽 추출물을 포함하는 항염증과 혈관계 질환 개선 효과 및 고혈압 예방과 치료 개선을 위한 약학 조성물
CN107397830A (zh) 2012-04-23 2017-11-28 奥斯陆大学 番茄提取物用作抗高血压剂的用途以及制造水溶性无糖番茄提取物的方法
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
JP2016044139A (ja) * 2014-08-22 2016-04-04 学校法人東京電機大学 タケ類抽出物及び新規配糖体
KR101855894B1 (ko) * 2016-07-13 2018-05-11 경희대학교 산학협력단 p-coumaric acid를 포함하는 호흡기 질환의 예방 또는 치료 효과를 갖는 약학조성물
CA3042720A1 (en) 2016-11-02 2018-05-11 Provexis Natural Products Limited Water soluble tomato extract protects against adverse effects of air pollution
KR102129534B1 (ko) * 2018-03-26 2020-07-03 가톨릭대학교 산학협력단 대나무 추출물을 유효성분으로 포함하는 줄기세포 증식 촉진용 조성물
US10918690B2 (en) * 2018-09-06 2021-02-16 Louise Wilkie Apparatus and method for processing organic bamboo leaf extract products
WO2020210140A1 (en) * 2019-04-06 2020-10-15 Banu Ip Llc Apparatus and method for processing organic bamboo leaf extract products
KR20230088290A (ko) * 2021-12-10 2023-06-19 재단법인 홍천메디칼허브연구소 사철쑥 및 죽순 추출물을 포함하는 장질환 예방 또는 치료용 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1560202A (pt) 1963-04-23 1969-03-21
US4201776A (en) * 1977-01-31 1980-05-06 The Green Cross Corporation Food additive for reinforcing foods deficient in fiber content
JPS5653619A (en) * 1979-10-10 1981-05-13 Wataru Sakai Separating method of active drug component from young bamboo
JPS5738721A (en) 1980-08-20 1982-03-03 Wataru Sakai Production of bamboo extract having effect for hemorrhoids
JPS5739753A (en) * 1980-08-22 1982-03-05 Wataru Sakai Healthful food containing bamboo extract
US5098709A (en) * 1987-07-21 1992-03-24 Kang Kwon J Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations
JPH03251518A (ja) 1990-02-26 1991-11-11 Ichimaru Pharcos Co Ltd 竹から抽出されたフケ菌発育阻害成分を含有する皮膚・頭皮・頭髪剤
JPH07300424A (ja) * 1993-12-27 1995-11-14 Sogo:Kk 抗腫瘍剤組成物
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
JP3488325B2 (ja) * 1995-09-28 2004-01-19 株式会社大和生物研究所 笹茶及びその製造方法
JPH09278662A (ja) 1996-04-10 1997-10-28 Nof Corp 抗アレルギー剤
CN1066055C (zh) 1998-03-17 2001-05-23 浙江农业大学 从竹叶中提取黄酮类化合物浸膏或粉剂的生产方法
JP2000317463A (ja) 1999-05-06 2000-11-21 Sanden Corp 殺菌・抗菌装置
JP2001187744A (ja) * 1999-10-19 2001-07-10 Tasuku Okuda 細胞活性化剤及びこれを用いた製品
JP2001245629A (ja) * 2000-03-07 2001-09-11 Api Co Ltd 医薬品又は健康食品用素材及びその製造方法
TWI233353B (en) * 2000-04-11 2005-06-01 Takara Bio Inc Therapeutic or preventive agents containing polyphenols
US20020146467A1 (en) * 2001-02-08 2002-10-10 Jung Kyu Yong Herbal composition for the prevention and treatment of dementia
JP2002322079A (ja) * 2001-04-25 2002-11-08 Bunshi Eiyogaku Kenkyusho:Kk ピロリ菌除菌組成物及びピロリ菌抗菌、除菌剤
US20040185124A1 (en) * 2002-10-24 2004-09-23 Hiromichi Hayashi Health food and antitumor agent
JP4080296B2 (ja) * 2001-10-24 2008-04-23 アダプトゲン製薬株式会社 抗腫瘍剤
JP2004161706A (ja) * 2002-11-14 2004-06-10 Api Co Ltd 健康食品、医薬品、化粧品並びに健康食品、医薬品又は化粧品用素材及びそれらの製造方法
CN1271083C (zh) * 2002-12-10 2006-08-23 杭州浙大力夫生物科技有限公司 从竹子中提取的三萜总皂甙元的组成、方法及其用途
JP2004217541A (ja) * 2003-01-10 2004-08-05 National Institute Of Advanced Industrial & Technology 腫瘍細胞傷害性ポルフィリン
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク． 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
KR100465113B1 (ko) 2004-01-15 2005-01-14 주식회사 유니젠 대나무 추출물 또는 이로부터 분리된 트리신을 포함하는조성물
KR100720971B1 (ko) * 2004-06-11 2007-05-22 주식회사 유니젠 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물
KR100720973B1 (ko) * 2005-03-18 2007-05-22 주식회사 유니젠 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물
KR100761248B1 (ko) * 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물

Also Published As

Publication number Publication date
CA2520207C (en) 2010-08-17
US20060078632A1 (en) 2006-04-13
JP4684893B2 (ja) 2011-05-18
EP1633379A4 (en) 2009-09-02
EP1633379A1 (en) 2006-03-15
US20110117224A1 (en) 2011-05-19
AU2004235702B2 (en) 2008-07-31
EP2213294A1 (en) 2010-08-04
CA2520207A1 (en) 2004-11-18
US20110280975A1 (en) 2011-11-17
JP2006515007A (ja) 2006-05-18
US20080107759A1 (en) 2008-05-08
AU2004235702A1 (en) 2004-11-18
US7897182B2 (en) 2011-03-01
WO2004098624A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
BRPI0408814A (pt) composição farmacêutica, e, alimento para o cuidado da saúde
WO2011064402A3 (fr) Extrait de graines d'acacia macrostachya et compositions le comprenant
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
CN104208654A (zh) 一种以地龙蛋白提取物为主的保健配方
EA021107B1 (ru) Комбинированная композиция, содержащая в качестве активного ингредиента l-карнитин или пропионил-l-карнитин, для предотвращения или лечения хронической венозной недостаточности
CN100594915C (zh) 治疗心脑血管疾病的中药提取物的制备方法及其用途
CN102579687A (zh) 鼻腔中药冲洗液
CN102641480B (zh) 用于治疗微循环障碍的中药组合物及其制备方法
CN104398643B (zh) 一种用于治疗皮炎湿疹的中药组合物
KR100682979B1 (ko) 항균 감염증 및 항염증 작용에 대한 예방 치료용 조성물 및이를 이용하여 얻어진 무좀치료제
Iermolenko et al. Theoretical justification of the search for potential medicinal products containing food plant biologically active substances
Muniandy et al. The action of Coleus aromaticus as a potential wound healing agent in experimentally induced diabetic mice
Jagannatha et al. An Updated Review on Ethnomedicinal Uses Phytochemistry and Pharmacological Activities of Couroupita guianensis.
Ediriweera A review on leech application (jalaukacharana) in ayurveda and sri lankan traditional medicine
KR20170051926A (ko) 붉은토끼풀(red clover, Trifolium pratense) 유래 Biochanin-A를 유효성분으로 하는 퇴행성관절염 예방 기능성 식품 조성물
Zhumaliyeva et al. Selected Kazakhstani plants with possible lymphatic properties.
Maniei et al. The use of aloe vera after infrared therapy in the treatment of a diabetic foot ulcer: a case report
KR101447657B1 (ko) 전나무 잎 추출물을 함유하는 항암 조성물
Chandio et al. The pharmacological effects of Curcuma longa linn in wound healing and relieving inflammation
CN104706998A (zh) 临床护理用治疗过敏性鼻炎的中药喷剂及其制备方法
Smith The Extracellular Matrix in Health and Disease: Naturopathic Approaches to Improve Structure and Function
Fizor et al. Sophora Japonica: the perspectives of use in a new medical form for prevention and treatment of couperose
KR20100028442A (ko) 백련 추출물을 포함하는 동맥 경화 예방 및 치료용 약학 조성물
CN105998313A (zh) 一种彻底治疗心脑血管疾病的中药配方
Murphy et al. H17 Traditional medicine: a warts-and-all tale

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT. CL. : A61K 35/78.

Ipc: A61K 36/899 (2006.01), A61P 9/00 (2006.01), A61P 2

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24, 8O C/C 13, 10, 22 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.